Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial.
Hoeper MM, Al-Hiti H, Benza RL, Chang SA, Corris PA, Gibbs JSR, Grünig E, Jansa P, Klinger JR, Langleben D, McLaughlin VV, Meyer GMB, Ota-Arakaki J, Peacock AJ, Pulido T, Rosenkranz S, Vizza CD, Vonk-Noordegraaf A, White RJ, Chang M, Kleinjung F, Meier C, Paraschin K, Ghofrani HA, Simonneau G; REPLACE investigators. Hoeper MM, et al. Among authors: gibbs jsr. Lancet Respir Med. 2021 Jun;9(6):573-584. doi: 10.1016/S2213-2600(20)30532-4. Epub 2021 Mar 24. Lancet Respir Med. 2021. PMID: 33773120 Clinical Trial.
A gene for primary pulmonary hypertension.
Wilkins MR, Gibbs JS, Shovlin CL. Wilkins MR, et al. Lancet. 2000 Oct 7;356(9237):1207-8. doi: 10.1016/s0140-6736(00)02777-x. Lancet. 2000. PMID: 11072932 No abstract available.
Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study.
Wilkins MR, Paul GA, Strange JW, Tunariu N, Gin-Sing W, Banya WA, Westwood MA, Stefanidis A, Ng LL, Pennell DJ, Mohiaddin RH, Nihoyannopoulos P, Gibbs JS. Wilkins MR, et al. Am J Respir Crit Care Med. 2005 Jun 1;171(11):1292-7. doi: 10.1164/rccm.200410-1411OC. Epub 2005 Mar 4. Am J Respir Crit Care Med. 2005. PMID: 15750042 Clinical Trial.
Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension.
Condliffe R, Kiely DG, Gibbs JS, Corris PA, Peacock AJ, Jenkins DP, Hodgkins D, Goldsmith K, Hughes RJ, Sheares K, Tsui SS, Armstrong IJ, Torpy C, Crackett R, Carlin CM, Das C, Coghlan JG, Pepke-Zaba J. Condliffe R, et al. Am J Respir Crit Care Med. 2008 May 15;177(10):1122-7. doi: 10.1164/rccm.200712-1841OC. Epub 2008 Feb 21. Am J Respir Crit Care Med. 2008. PMID: 18292468
Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension.
Nickel N, Kempf T, Tapken H, Tongers J, Laenger F, Lehmann U, Golpon H, Olsson K, Wilkins MR, Gibbs JS, Hoeper MM, Wollert KC. Nickel N, et al. Am J Respir Crit Care Med. 2008 Sep 1;178(5):534-41. doi: 10.1164/rccm.200802-235OC. Epub 2008 Jun 19. Am J Respir Crit Care Med. 2008. PMID: 18565955
Therapeutic targets in pulmonary arterial hypertension.
Rhodes CJ, Davidson A, Gibbs JS, Wharton J, Wilkins MR. Rhodes CJ, et al. Pharmacol Ther. 2009 Jan;121(1):69-88. doi: 10.1016/j.pharmthera.2008.10.002. Epub 2008 Oct 28. Pharmacol Ther. 2009. PMID: 19010350 Review.
Updated evidence-based treatment algorithm in pulmonary arterial hypertension.
Barst RJ, Gibbs JSR, Ghofrani HA, Hoeper MM, McLaughlin VV, Rubin LJ, Sitbon O, Tapson VF, Galiè N. Barst RJ, et al. Among authors: gibbs jsr. J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S78-S84. doi: 10.1016/j.jacc.2009.04.017. J Am Coll Cardiol. 2009. PMID: 19555861 Free PMC article. Review.
End points and clinical trial design in pulmonary arterial hypertension.
McLaughlin VV, Badesch DB, Delcroix M, Fleming TR, Gaine SP, Galiè N, Gibbs JSR, Kim NH, Oudiz RJ, Peacock A, Provencher S, Sitbon O, Tapson VF, Seeger W. McLaughlin VV, et al. Among authors: gibbs jsr. J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S97-S107. doi: 10.1016/j.jacc.2009.04.007. J Am Coll Cardiol. 2009. PMID: 19555863 Free article. Review.
162 results